Canada needs to step up its biopharmaceutical game By Pamela Fralick. Published on Jun 16, 2021 5:42pm 'As vaccines unlock economies worldwide, we witness the power of accessible vaccines and the benefits of resilient working relationships.' A vial of Moderna's COVID-19 vaccine (Wikimedia Commons) It’s been said time and again in recent months, but it bears repeating: The development of COVID-19 vaccines now being deployed testifies to the collaboration and innovation of industries and governments. It underscores the art of the possible. Of the countless concerns the pandemic has created, access to these vaccines, as well as treatments and diagnostics, remains at the forefront of leaders’ minds. We saw this at the G7 summit over the weekend.